Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (5 ops.)
Latest filing published 04 Feb 2026 for Akebia Therapeutics, Inc., €42k.
Filing timeline
BuySaleRichard C. Malabre
Insider track record
Disclosed buys
0
Disclosed sells
5
Signal history
Richard C. Malabre: trading record in brief
This profile gathers the share dealings of Richard C. Malabre in Akebia Therapeutics, Inc. In total, 9 filings cover trades dated from 31 January 2024 to 2 February 2026.
On the market, this insider has only sold: 5 sales, €214k in total. Other entries cover 3 share grants and 1 option exercise. 2026 to date brings no purchases and 2 sales.
Most recently, on 4 February 2026, the filings show an open-market sale worth €16k in Akebia Therapeutics, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Richard C. Malabre
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations6 total
36,142 shares@ US$1.3940.1% of flowCommon StockSEC:0002007730-26-000002:0
79,000 shares0Common StockSEC:0002007730-26-000001:0
15,000 shares@ US$1.6820.9% of flowCommon StockSEC:0001562180-25-004717:0
13,334 shares@ US$3.5339.0% of flowCommon StockSEC:0001562180-25-004491:0
85,000 shares0Common StockSEC:0001562180-25-000915:0
223,950 shares0Common StockSEC:0001562180-24-000980:0
6 of 6 declarations
